Cognition Therapeutics, Inc. Other Assets
Cognition Therapeutics, Inc. (CGTX) had Other Assets of $1.75 million as of 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Balance Sheet › Assets
us-gaap:OtherAssets · last filed 2024-03-26
- 2023-09-30: Other Assets $1.75M.
- 2023-06-30: Other Assets $1.43M.
- 2023-03-31: Other Assets $1.83M.
- 2022-12-31: Other Assets $1.73M.
| Period end | Other Assets |
|---|---|
| 2023-09-30 | $1.75M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.43M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.83M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.73M 10-K · filed 2024-03-26 |
| 2022-09-30 | $1.69M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.28M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.42M 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |